SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Mark One)
[x] Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act
of 1934 [Fee Required] AMENDMENT #1
For the fiscal year ended June 30, 1996 or
[ ] Transition report pursuant to section 13 or 15(d) of the Securities
Exchange Act of 1934 [No Fee Required]
For the transition period from N/A to N/A
Commission file number 0-12984
ADVANCED TOBACCO PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
State of Texas 74-2285214
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
16607 Blanco Road, Suite 1504 78232
San Antonio, Texas (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (210)408-7077
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange
on which registered
None None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
(Title of Class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes X No
Part IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND
REPORTS ON FORM 8-K
(a) The following documents are filed as part of this Annual Report on
Form 10-K:
1. Financial Statements and Independent Auditors' Report
The financial statements and opinion listed in the index to financial
statements follows the signature page of this report.
2. Financial Statement Schedules
The Company did not meet any of the requirements to provide financial
statement schedules for any of the fiscal years ended 1995, 1994 or 1993.
3. Exhibits
Exhibit 23.2 - Consent of Independent Public Accountants
(b) The Company has filed the following Current Reports on Form 8-K since
the filing of the Company's last 10-K:
Form 8-K filed June 7, 1996, regarding New Drug Application filed by
Pharmacia & Upjohn.
SIGNATURES
Pursuant to the requirements of the Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be
signed on behalf by the undersigned, thereunto duly authorized, in the
City of San Antonio, State of Texas, as of October 22, 1996.
ADVANCED TOBACCO PRODUCTS, INC.
Date: October 22, 1996 By: /s/ J. W. LinehanJ. W. Linehan, President, Chief
Executive Officer and Chief
Accounting Officer
ABB0DB4E
Exhibit 23.2
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the incorporation
of our report included in this Form 10-K into the Company's previously filed
Registration Statement on Form S-8 (File No. 33-15694).
/s/ ARTHUR ANDERSEN LLP ARTHUR ANDERSEN LLP
San Antonio, Texas
October 18, 1996
